# Tyra Biosciences

**Canonical:** https://apis.io/providers/tyra/  
**Website:** https://tyra.bio/  
**APIs profiled:** 0

Tyra Biosciences is a clinical-stage biopharmaceutical company (NASDAQ: TYRA) based in Carlsbad, California, focused on developing next-generation precision medicines that address the emergence of tumor resistance and other challenges in existing treatment options. Tyra's proprietary in-house SNAP discovery platform combines advanced protein crystallography with structure-based drug design, producing full structural "SNAPshots" of the real-world interaction between a drug and its target in as little as seven days rather than weeks to months. This rapid, sequential structural iteration lets the team refine molecular designs to angstrom-level precision and design selective inhibitors intended to deliver deeper, more durable responses for patients, including in cancers where resistance mutations block first-generation drugs. Tyra was surfaced as a portfolio company of Canaan Partners. It is a therapeutics company and does not publish a public developer API, SDK, or API documentation surface.

## Kin Score — 10.0 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 10.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 4.8 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Tyra Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Precision Medicine, Drug Discovery, Oncology, Therapeutics, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/tyra/). Scores are computed from the provider's own public artifacts under a published rubric.